2626 Cole Ave. Suite 504, LB 24
Dallas, TX 75204
214-871-2772
Penn Davis McFarland

What We’re Reading – Week of 07/31/2015

Below you will find the articles on economics, investing, and finance that we found most interesting for the week.

NB: ($) denotes subscription site.

 

A last-minute call led to Teva buying Allergan’s generics business, despite months of chasing Mylan.

Article via Bloomberg

 

Biotech high flyers face the gravity test.

Article via Financial Times ($)

 

The law of unintended consequences rears its head when it comes to “secret” IPO filings.  Rather than going public, companies are using the filings to shop themselves to private buyers.

Article via Wall Street Journal ($)

 

The FT had an in-depth look at prescription painkiller abuse this week.

Article via Financial Times ($)

 

Can the insurance industry survive driverless cars?

Article via Bloomberg

 

GMO has some interesting commentary on price insensitive buyers and other things that might make one cautious.

Letter via GMO